Trade receivables increased 24.0%
Trade receivables changed +24.0% from the comparable as-filed period.
$217.0M→$269.2M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →RBRK financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
SBC / revenue moved 490 bp lower
SBC / revenue changed -490 basis points from the comparable as-filed period.
28.55%→23.64%2 prior comparisons
Free-cash-flow margin moved 308 bp lower
Free-cash-flow margin changed -308 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
19.76%→16.68%2 prior comparisons
Operating cash-flow margin moved 290 bp lower
Operating cash-flow margin changed -290 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
20.89%→17.99%2 prior comparisons
Total assets increased 19.1%
Total assets changed +19.1% from the comparable as-filed period.
$2.4B→$2.8B3 prior comparisons
Capital expenditure increased 60.1%
Capital expenditure changed +60.1% from the comparable as-filed period.
$3.5M→$5.6M3 prior comparisons
Inventory increased 35.0%
Inventory changed +35.0% from the comparable as-filed period.
$5.0M→$6.8M3 prior comparisons
Receivables / revenue moved 704 bp lower
Receivables / revenue changed -704 basis points from the comparable as-filed period.
70.05%→63.01%2 prior comparisons
Current assets increased 17.8%
Current assets changed +17.8% from the comparable as-filed period.
$1.9B→$2.3B3 prior comparisons
Gross margin moved 105 bp lower
Gross margin changed -105 basis points from the comparable as-filed period.
79.49%→78.44%2 prior comparisons
Current ratio decreased 9.8%
Current ratio changed -9.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
1.82→1.643 prior comparisons
Stock-based compensation increased 14.2%
Stock-based compensation changed +14.2% from the comparable as-filed period.
$88.5M→$101.0M2 prior comparisons
Capex / revenue moved 18 bp higher
Capex / revenue changed +18 basis points from the comparable as-filed period.
1.13%→1.31%2 prior comparisons
Inventory / revenue moved 3 bp lower
Inventory / revenue changed -3 basis points from the comparable as-filed period.
1.62%→1.58%2 prior comparisons
Working capital increased 2.3%
Working capital changed +2.3% from the comparable as-filed period.
$868.5M→$888.1M3 prior comparisons
R&D / revenue moved 3 bp lower
R&D / revenue changed -3 basis points from the comparable as-filed period.
29.73%→29.69%2 prior comparisons
SBC / revenue moved 745 bp lower
SBC / revenue changed -745 basis points from the comparable as-filed period. The change ranks at the 11th percentile of 9 prior comparable changes.
26.41%→18.95%9 prior comparisons
Capital expenditure increased 50.1%
Capital expenditure changed +50.1% from the comparable as-filed period. The change ranks at the 60th percentile of 5 prior comparable changes.
$2.9M→$4.3M5 prior comparisons
Inventory / revenue moved 17 bp higher
Inventory / revenue changed +17 basis points from the comparable as-filed period. The change ranks at the 20th percentile of 5 prior comparable changes. This reverses 5 consecutive comparable moves in the opposite direction.
1.65%→1.82%5 prior comparisons
Capex / revenue moved 8 bp higher
Capex / revenue changed +8 basis points from the comparable as-filed period. The change ranks at the 20th percentile of 5 prior comparable changes.
1.02%→1.10%5 prior comparisons
Stock-based compensation decreased 0.2%
Stock-based compensation changed -0.2% from the comparable as-filed period. The change ranks at the 0th percentile of 9 prior comparable changes.
$73.5M→$73.4M9 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.